• Pfizer files lung cancer drug in the EU, US pharmatimes
    July 18, 2018
    Pfizer has filed its pan-human epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor dacomitinib on both sides of the Atlantic for a particular form of lung cancer.
PharmaSources Customer Service